A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
ConditionAsthma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorSanofi
About this trial
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life.
The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Eligibility criteria
Qualifiers
Age 6 years and older, at the time of signing the informed consent
Physician diagnosis of asthma for at least 12 months
Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps
Participant or legally authorized representative (where applicable) has consented to participate
Disqualifiers
None
Trial design
Treatments tested in this trial
- Procedure: Investigational Procedures
- Procedure: Investigational Procedures
Treatment groups
2,500 Participants
are divided into 5 treatment groupsSponsors and collaborators
Sanofi
Lead sponsor
Syneos Health
Collaborator
Source ClinicalTrials.gov